ID: ALA3673256

Max Phase: Preclinical

Molecular Formula: C10H19NO4S

Molecular Weight: 249.33

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(C)(C)OC(=O)C[C@H](N)/C=C/S(C)(=O)=O

Standard InChI:  InChI=1S/C10H19NO4S/c1-10(2,3)15-9(12)7-8(11)5-6-16(4,13)14/h5-6,8H,7,11H2,1-4H3/b6-5+/t8-/m1/s1

Standard InChI Key:  NRMCWADOPNVXKA-HQZHTGGTSA-N

Associated Targets(Human)

Caspase-5 109 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Caspase-7 3146 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Caspase-1 6235 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Caspase-9 154 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Caspase-3 3632 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 249.33Molecular Weight (Monoisotopic): 249.1035AlogP: 0.60#Rotatable Bonds: 4
Polar Surface Area: 86.46Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 8.13CX LogP: -0.60CX LogD: -1.40
Aromatic Rings: 0Heavy Atoms: 16QED Weighted: 0.74Np Likeness Score: 0.26

References

1.  (2015)  Selective caspase inhibitors and uses thereof, 

Source

Source(1):